← Open Payments lookup

SUSAN ALDEN: Open Payments

NPI 1629079280 · MILAN, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,099 in 94 payments from 26 companies in 2025. Trend: 2023 $1,083 · 2024 $2,218 · 2025 $2,099

Food & beverage: $2,099
CompanyPaymentsAmount
ABBVIE INC.17$423
Vanda Pharmaceuticals Inc.13$363
Alkermes, Inc.8$192
Axsome Therapeutics, Inc.4$110
Novo Nordisk Inc4$84
E.R. Squibb & Sons, L.L.C.4$81
Teva Pharmaceuticals USA, Inc.4$75
Lilly USA, LLC4$72
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$70
AstraZeneca Pharmaceuticals LP4$69

Products named: FANAPT, VRAYLAR, LYBALVI, Auvelity, REXULTI, COBENFY, AUSTEDO XR, CAPLYTA.

Industry payments across IL — which companies pay providers there.